At the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Umberto Vitolo (Città della Salute e della Scienza di Torino, Turin, Italy) discusses recent advances in the management of mantle cell lymphoma, including a maintenance approach for young patients and ibrutinib therapy for relapsed patients.